Vanguard Group Inc Soleno Therapeutics Inc Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $2.48 $325,728 - $5.05 Million	-2,035,806 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.14 - $0.23 $2,246 - $3,690	-16,045 Reduced 0.78%	2,035,806 $377,000
Q1 2022 May 13, 2022	SELL	$0.22 - $0.47 $2,759 - $5,894	-12,541 Reduced 0.61%	2,051,851 $457,000
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.91 $1,689 - $3,749	-4,120 Reduced 0.2%	2,064,392 $846,000
Q2 2021 Aug 13, 2021	BUY	$0.97 - $1.32 $2.01 Million - $2.73 Million	2,068,512 New	2,068,512 $2.36 Million

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $420M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.